Literature DB >> 7680799

CP-96,345, but not its stereoisomer, CP-96,344, blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat.

K Yashpal1, V Radhakrishnan, T J Coderre, J L Henry.   

Abstract

The effects of subcutaneous administration of the non-peptide NK-1 (substance P) receptor antagonist, CP-96,345, and its stereoisomer, CP-96,344, were tested in three nociceptive paradigms in the rat. In the first paradigm, tail flick responses were monitored before and after intrathecal administration of substance P (6.5 nmol) in rats pretreated subcutaneously with saline, CP-96,344 (5 mg/kg) or CP-96,345 (5 mg/kg). In the control groups, pretreated with saline (n = 6) or with CP-96,344 (n = 5), substance P reduced the tail flick reaction time at 1 min after administration to 38.3 +/- 5.1 (mean +/- S.E.M.) and 32.1 +/- 7.7% of the mean baseline value, respectively. In contrast, in the group pretreated with CP-96,345 (n = 6) the reaction time following administration of substance P was 98.8 +/- 3.3% of the baseline reaction time; this value was not significantly different from the baseline value of this group, indicating a block (P < 0.01) of the substance P-induced facilitation of the tail flick response. In the second paradigm, rats were anesthetized with a mixture of chloral hydrate (120 mg/kg, i.p.) and sodium pentobarbital (20 mg/kg, i.p.), and the effects were determined on tail flick reaction time of a sustained noxious cutaneous stimulation, immersing the tip of the tail in hot water at 55 degrees C. In the groups of rats pretreated with saline (n = 4) or with CP-96,344 (n = 7), this noxious stimulus produced a transient decrease in reaction time to 62-74% of the baseline value.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680799     DOI: 10.1016/0306-4522(93)90550-y

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  9 in total

1.  Antidepressant-like effects of neurokinin receptor antagonists in the forced swim test in the rat.

Authors:  Liliane J Dableh; Kiran Yashpal; Joseph Rochford; James L Henry
Journal:  Eur J Pharmacol       Date:  2004-12-28       Impact factor: 4.432

2.  Central versus peripheral site of action of the tachykinin NK1-antagonist RP 67580 in inhibiting chemonociception.

Authors:  U Holzer-Petsche; T Rordorf-Nikolić
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

3.  Tachykinin-1 receptor antagonism suppresses substance-P- and compound 48/80-induced mast cell activation from rat mast cells expressing functional mas-related GPCR B3.

Authors:  Muhammad N A Sahid; Shuang Liu; Masaki Mogi; Kazutaka Maeyama
Journal:  Inflamm Res       Date:  2020-01-28       Impact factor: 4.575

4.  Evidence for tonic activation of NK-1 receptors during the second phase of the formalin test in the Rat.

Authors:  J L Henry; K Yashpal; G M Pitcher; J Chabot; T J Coderre
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

5.  Contribution of neurokinin 1 receptors in the cutaneous orofacial inflammatory pain.

Authors:  Philippe Luccarini; Mélaine Henry; Pedro Alvarez; Anne-Marie Gaydier; Radhouane Dallel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-09-27       Impact factor: 3.000

6.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils.

Authors:  N M Rupniak; J K Webb; A R Williams; E Carlson; S Boyce; R G Hill
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

8.  Physiological evidence of a postsynaptic inhibition of the tail flick reflex by a cannabinoid receptor agonist.

Authors:  Liliane J Dableh; Kiran Yashpal; James L Henry
Journal:  Eur J Pharmacol       Date:  2008-11-09       Impact factor: 4.432

9.  Bioactive Fraction of Annona reticulata Bark (or) Ziziphus jujuba Root Bark along with Insulin Attenuates Painful Diabetic Neuropathy through Inhibiting NF-κB Inflammatory Cascade.

Authors:  Raghuram Kandimalla; Suvakanta Dash; Sanjeeb Kalita; Bhaswati Choudhury; Sandeep Malampati; Rajlakshmi Devi; Muthiah Ramanathan; Narayan C Talukdar; Jibon Kotoky
Journal:  Front Cell Neurosci       Date:  2017-03-22       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.